StandardX, a London-based startup, has raised £10m in seed funding to build the infrastructure needed to manufacture rare medical materials. The round was led by Vsquared and East X, two investors with track records in deep tech, having previously backed Neura Robotics and Proxima Fusion respectively.
The company is focused on addressing supply-chain challenges in the production of specialised medical materials, which are currently difficult to source. The funding will support StandardX's early development as it looks to scale its manufacturing approach.
Beyond the round details and the lead investors, the source does not provide additional specifics on the company's technology or timeline. This article reflects only the information stated in the original report.